KEMEDIUM SIGNALFINANCIAL10-K

KE substantially reduced its debt burden by half while experiencing notable declines in profitability and operating scale.

The company appears to be prioritizing balance sheet strength through significant deleveraging, which reduced interest expense and financial risk. However, the concurrent decline in gross profit and overall business scale suggests either a strategic downsizing or challenging operating conditions that warrant investor attention.

Comparing 2025-08-22 vs 2024-08-23View on EDGAR →
FINANCIAL ANALYSIS

KE executed a major deleveraging initiative, cutting total debt in half from $294.8M to $147.1M, which correspondingly reduced interest expense by over one-third. However, the company experienced meaningful contractions across key operating metrics, with gross profit declining to $104.4M, SG&A expenses falling to $50.3M, and net income dropping to $17.0M. The overall financial picture suggests a company that has strengthened its balance sheet through debt reduction but is operating at a reduced scale, with lower profitability reflecting either strategic restructuring or market pressures.

FINANCIAL STATEMENT CHANGES
Total Debt
Balance Sheet
-50.1%
$294.8M$147.1M

Debt reduced 50.1% — deleveraging strengthens balance sheet and reduces financial risk.

Interest Expense
P&L
-35.4%
$22.8M$14.7M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Capital Expenditure
Cash Flow
-27.8%
$46.1M$33.3M

Capex reduced 27.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Gross Profit
P&L
-25.6%
$140.3M$104.4M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

SG&A Expense
P&L
-24.5%
$66.6M$50.3M

SG&A reduced 24.5% — improved cost efficiency or headcount reduction improving operating margins.

Inventory
Balance Sheet
-19.1%
$338.1M$273.5M

Inventory reduced 19.1% — lean inventory management or demand outpacing supply.

Current Assets
Balance Sheet
-17.4%
$847.0M$699.6M

Current assets declined 17.4% — monitor working capital adequacy and short-term liquidity.

Net Income
P&L
-17.2%
$20.5M$17.0M

Net income declined 17.2% — review whether driven by operations, interest costs, or non-recurring items.

Current Liabilities
Balance Sheet
-15.1%
$375.3M$318.6M

Current liabilities reduced — improved short-term financial position and working capital health.

Total Liabilities
Balance Sheet
+14.2%
$186.2M$212.7M

Liabilities increased 14.2% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2025-08-22
PRIOR — 2024-08-23
ADDED
We deliver a package of value that includes durable, high-reliability electronics, higher level and final assemblies, and contract manufacturing organization ( CMO ) solutions.
Our CMO solutions support the production of medical disposables and drug delivery devices, from precision molded plastics and cold chain management to drug integration.
Customers and industry trade publications regularly award us for our design and manufacturing expertise that, coupled with robust processes and procedures, help us ensure that we deliver the highest levels of quality, reliability, and innovative service throughout the entire life cycle of our customers products.
Our Customer Relationship Management ( CRM ) model is key to providing our customers convenient access to our highly integrated global footprint, enabled by our largely standardized operating system and procedures.
As of June 30, 2025, all of our operating segments provided contract manufacturing services, including engineering and supply chain support, for the production of electronic assemblies and other products including medical devices, medical disposables, and precision molded plastics primarily in automotive, medical, and industrial applications, to the specifications and designs of our customers.
Our Business Offerings For 40 years, we have manufactured safety-critical electronic assemblies for automotive customers, developing invaluable expertise that extends beyond the automotive industry to benefit our medical and industrial customers as well.
Many of our customers are multinational companies operating across multiple global regions, and they maximize their supplier relationship by partnering with us at multiple facilities across these locations and regions.
We leverage key supply chain advantages and our streamlined operations to cost-effectively manufacture both electronic and non-electronic products, from high volume-low mix to high mix-low volume, within a single production facility for customers from all three of our end market verticals.
Our robust new product introduction process and our extensive manufacturing capabilities give us the ability to execute to the various quality and reliability expectations of each of our customers.
Our CRM model and our strategic approach to expanding our global footprint aligns with our customers preferences in our three end market verticals allowing us to support their global growth initiatives.
REMOVED
We deliver a package of value that begins with our core competency of producing durable electronics and further offer contract manufacturing services for non-electronic components, medical disposables, drug delivery solutions and precision molded plastics.
Our design and manufacturing expertise coupled with robust processes and procedures help us ensure that we deliver the highest levels of quality and reliability throughout the entire life cycle of our customers products.
We deliver award-winning service across our global footprint with an operations platform driven by highly integrated procedures, standardization, and teamwork.
Our Customer Relationship Management ( CRM ) model is key to providing our customers convenient access to our global footprint and all of our services throughout the entire product life cycle.
For over 35 years, we have manufactured safety-critical electronic assemblies for automotive customers, developing invaluable expertise that extends beyond the automotive industry to benefit our medical and industrial customers as well.
Many of our customers are multinational companies operating across multiple global regions, and they maximize their supplier relationship by partnering with us for engineering, manufacturing, and supply chain services and support across multiple locations and regions.
We leverage key supply chain advantages and streamline our operations, enabling cost-effective manufacturing of both electronic and non-electronic products within a single production facility for customers from all three end market verticals.
Coupled with our CRM model and our global systems, procedures, processes, and teamwork, our strategic approach to expanding our global footprint aligns with our customers preferences in our three end market verticals.
This positions us strongly to support their global growth initiatives.
Our central sourcing organization employs global procurement strategies that ensure consistent component availability and a uniform pricing approach by leveraging the purchasing volume of our entire organization.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →